Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug-excipient compatibility

Incompatibilities have also been observed in solid dosage forms. A typical tablet contain binders, disin-tegrants, lubricants and fillers. Compatibility screening for a new drug should consider two or more excipients from each class. Serajuddin et al. have developed a drug-excipient compatibility screening model to predict interactions of drug substances with excipients [49],... [Pg.151]

Thermal methods can be extremely useful during the course of preformulation studies, since carefully planned work can be used to indicate the existence of possible drug-excipient interactions in a prototype formulation [2]. During the course of this aspect of drug development, thermal methods can be used to evaluate compound purity, polymorphism, solvation, degradation, drug-excipient compatibility, and a wide variety of other desirable characteristics. Several recent reviews have been written on such investigations [2-6]. [Pg.224]

Serajuddin, A.T.M., Thakur, A.B., Ghoshal, R.N., Fakes, M.G., and Varia, S.A., Selection of solid dosage form composition through drug-excipient compatibility testing, /. Pharm. Sci., 88, 696, 1999. [Pg.48]

However, as might be anticipated, there is no universal panacea to drug stabilisation. Basic excipients can also destabilise formulations. Serajuddin et al. [19] reported on the drug-excipient compatibility of a calcium channel... [Pg.28]

Serajuddin, A. T. M., A. B. Thakur, R. N. Ghoshal, M. G. Fakes, S. A. Ranadive, K. R. Morris, and S. A. Varia. 1999. Selection of dosage form composition through drug-excipient compatibility testing. [Pg.528]

Formulation profile, which consists of physical and chemical characteristics required for the products, drug-excipient compatibility studies, and the effect of formulation on in vitro dissolution... [Pg.50]

Sims JL, Carreira JA, Carrier DJ, Crabtree SR, Easton L, Hancock SA, Simcox SR. A new approach to accelerated drug-excipient compatibility testing. Pharm Dev Technol 2003 8(2) 119-126. [Pg.46]

Other examples of the use of microcalorimetry to study drug-excipient compatibility in the solid state are provided by Selzer et al. (30), who studied the interaction between a solid drug and a range of excipients [including potato starch, a-lactose-monohydrate, microcrystalline cellulose (MCC), and talc] and Schmitt (31) who used water slurries instead of humidified samples. [Pg.344]

Wissing S, Craig DQM, Barker SA, Moore WD. An investigation into the use of stepwise isothermal high sensitivity DSC as a means of detecting drug-excipient compatibility. Int J Pharm 2000 199 141-150. [Pg.354]

Serajuddin A, Thakur A, Ghoshal R, Fakes M, Ranadive S, Morris K, Varia S. Selection of solid dosage form composition through drug-excipient Compatibility Testing. J Pharm Sci 1999 88(7) 696-704. [Pg.455]

Some excipients contain a certain amount of amorphous form such as spray-dried lactose,27 and others are hygroscopic, such as microcrystalline cellulose.28 These excipients will adsorb water, which causes a change in the micro-environment of the formulation. If the drug substance is moisture-sensitive, degradation may occur quickly. Therefore, consider both drug-excipient compatibility and excipient impurity profile in selecting excipients for low-dose drug products. [Pg.36]

TABLE 10 Examples of Binary and Factorial Designs for Drug-Excipient Compatibility Studies ... [Pg.897]

Understanding the degradation chemistry of drug with excipients is essential to select proper excipients in the formulation stages [16, pp 101-151]. Drug-excipient compatibility studies are crucial to decide optimal tablet formulation and to understand the possible mechanism in many cases [10,12,14], Drug instability occurs by three types of reactions hydrolysis, oxidation, and aldehyde-amine addition. Table 11 gives reaction types of chemical and physical instability. [Pg.898]

In conclusion, drug-excipient compatibility studies have a key role at the early preformulation stages to select excipients or after formulation to help identify the mechanism of any detected instability [14], An understanding of the potential physicochemical interactions of drug with known chemical reactivities of excipients and... [Pg.900]


See other pages where Drug-excipient compatibility is mentioned: [Pg.48]    [Pg.250]    [Pg.13]    [Pg.73]    [Pg.27]    [Pg.27]    [Pg.28]    [Pg.28]    [Pg.24]    [Pg.24]    [Pg.25]    [Pg.520]    [Pg.656]    [Pg.18]    [Pg.36]    [Pg.238]    [Pg.425]    [Pg.35]    [Pg.236]    [Pg.244]    [Pg.881]    [Pg.881]    [Pg.881]    [Pg.882]    [Pg.896]    [Pg.897]    [Pg.897]    [Pg.897]    [Pg.899]    [Pg.899]    [Pg.901]    [Pg.901]   
See also in sourсe #XX -- [ Pg.37 , Pg.437 ]

See also in sourсe #XX -- [ Pg.969 ]




SEARCH



Compatibility drug/excipient interactions

Drug substances excipient compatibility studies

Drug-excipient compatibility experimental design

Drug-excipient compatibility studies

Excipient

Excipient compatibility

Excipients

Excipients compatibility, drug products

Excipients drug compatibility

Excipients drug compatibility

© 2024 chempedia.info